Why Visibility Comes Before Control

The argument beneath the argument

Few relationships in healthcare generate more friction than the relationship between payers and providers. Providers describe interference, administrative burden, and payment delay. Health plans describe unwarranted variation, incomplete information, and insufficient accountability for total cost and outcomes. Each side can produce evidence supporting its position. Yet the visible dispute over prior authorization, medical necessity, documentation, and reimbursement may obscure a more fundamental problem: uncertainty.

When a payer cannot determine whether clinical risk is being recognized and managed reliably, it introduces controls. When a provider believes those controls are based on incomplete or inaccurate information, it resists them. The result is a recurring cycle of oversight, burden, challenge, reform, and escalation. More rules—or more efficient versions of the same rules—seldom resolve the underlying disagreement because the parties are not merely arguing about policy. They are operating from different and incomplete representations of reality.

The critical question is not simply who should control care. It is who can demonstrate that care is being effectively managed.

Control is often a substitute for confidence

Healthcare controls are usually explained as mechanisms for managing cost, quality, compliance, or utilization. That explanation is accurate but incomplete. Controls also arise when one party cannot confidently observe another party’s decisions, performance, or results.

Prior authorization is a useful example. Public debate often treats it as either a necessary safeguard or an inappropriate intrusion into clinical care. In practice, it may be both, depending on how it is designed and applied. At a structural level, it also functions as a response to uncertainty.

The health plan does not directly observe the clinical reasoning, workflow, or longitudinal context surrounding a proposed service. Much of what the plan routinely receives is an administrative representation of care—most often a claim submitted after the service has been rendered. The claim may accurately contain the information required to process reimbursement without fully explaining the patient’s condition, the alternatives considered, the reasoning behind the decision, or how the service fits into the patient’s care over time. Even when additional clinical information is requested before a service, it is generally assembled to support a defined administrative determination rather than to reproduce the provider’s complete view of the patient.

The provider, in turn, does not necessarily see the plan’s broader utilization patterns, benefit obligations, population-level exposure, or the evidence and decision logic that cause one request or provider to be treated differently from another. A prospective review process is inserted between them because neither side has enough visibility to rely confidently on the other’s information, reasoning, or incentives.

The same logic applies to retrospective audits, documentation requests, medical-necessity reviews, quality scorecards, and many contracting requirements. These mechanisms do not exist only because organizations seek control. They also exist because confidence is insufficient to support autonomy.

Reforming the control is not the same as resolving its cause

Current efforts to make authorization electronic, reduce requirements, or exempt selected high-performing providers may improve important parts of the process. Faster transactions, clearer standards, better status information, and fewer unnecessary reviews can reduce burden and delay. Those improvements have value.

These reforms should not be mistaken for resolution of the underlying condition. Digitizing a control changes how it is administered; applying it more selectively changes where it is used. Neither, by itself, establishes whether care is appropriate, clinical risk is being managed, or a provider has demonstrated the capability that could justify greater autonomy.

The designation “high performing” illustrates the problem. The designation may be reasonable, but its usefulness depends on the evidence beneath it. High performing according to which measures, for which populations, over what period, and with what relationship to the individual care decision? Without a sufficiently shared and defensible basis for the designation, the label may substitute for the visibility the parties still do not possess.

Visibility is more than access to data

Healthcare organizations rarely suffer from a complete absence of data. They suffer from fragmented context, inconsistent definitions, delayed signals, and limited ability to connect information to accountable action. More data does not necessarily create better visibility.

Claims data can provide a broad and valuable view of services, diagnoses, utilization, and cost. But a claim is constructed primarily to support an administrative and reimbursement process. Accuracy for that purpose is not the same as completeness for understanding the clinical reasoning, operating capability, or accountable action behind the care.

Useful visibility allows an organization to distinguish what it knows from what it assumes. It connects clinical conditions, encounters, referrals, transitions, utilization, documentation, decisions, and outcomes across time. It makes variation observable and attribution more defensible. Most importantly, it identifies where intervention is warranted and where it is not.

Visibility is not a dashboard. It is an operating capability. It depends on reliable information exchange, common definitions, workflow integration, analytical discipline, and governance. If the information cannot support a decision, withstand challenge, or trigger timely action, the organization may have reporting without meaningful visibility.

Visibility does not require seeing everything

Visibility does not require a payer to operate inside a provider’s clinical systems, nor does it require a provider to see every element of a payer’s population analysis, contractual obligations, or internal decision processes. Complete access is neither realistic nor necessary. What matters is whether each party can make the information relevant to the other party’s decision sufficiently clear, reliable, and actionable.

A provider should be able to use its clinical systems, infrastructure, workflows, and management practices to demonstrate that it recognizes patient risk, makes appropriate decisions, coordinates action, manages material variation, and evaluates whether care is producing the intended result. The payer should be able to explain the evidence, obligations, population patterns, and uncertainties that cause it to apply a control, question a decision, or treat one provider differently from another.

This is not simply an exchange of additional data. It is the disciplined translation of internal information and operating capability into evidence another party can understand and reasonably rely upon. The objective is not perfect transparency. It is enough reciprocal visibility to make accountability explicit and intervention proportionate.

From visible to manageable

Provider organizations may increasingly differentiate themselves not solely through claims of clinical excellence, but through the ability to make patient health visible and manageable. Every credible health system makes claims of quality; the more consequential distinction may be whether it can demonstrate the capability behind them.

Visible means that morbidity, emerging risk, care gaps, transitions, clinical decisions, and patterns of utilization can be recognized and explained. Manageable means that the organization can translate those signals into coordinated action, assign responsibility, follow through, and measure whether the action changed the result.

The two capabilities must develop together. Visibility without operational response produces awareness but little value. Intervention without reliable visibility produces waste, friction, and avoidable risk. The strategic asset is the combination: an organization’s demonstrable ability to understand a population and act on that understanding consistently.

A different payer-provider proposition

Consider a payer telling the CEO of an integrated health system: “We do not want to control your providers. We want confidence that you and your providers are controlling clinical risk effectively.”

The statement can be interpreted as an offer of partnership or as a prelude to risk transfer. A prudent health-system CEO would hear both. The payer may be prepared to reduce administrative intervention if the system can demonstrate reliable performance. It may also expect the health system to accept greater accountability for cost and outcomes.

The productive response is not an immediate agreement or rejection. It is a demand for specificity. What evidence would establish confidence? Which controls would be reduced? Which risks would transfer? How would performance be attributed? What must each party make visible to the other? Which data would be shared, and under what governance? What remedies would apply when results depart from expectations?

These questions move the relationship beyond broad promises of alignment. They convert confidence into an operating and contractual proposition.

The revenue model cannot be ignored

For many health systems, the aspiration to manage clinical risk exists alongside a revenue model still dependent on service volume. Better chronic-condition management may reduce avoidable admissions. Better care coordination may reduce redundant testing. More appropriate site-of-service decisions may shift revenue away from higher-cost settings. Under fee-for-service economics, activities that improve affordability for the system as a whole may weaken revenue for an individual provider organization.

This tension is not evidence of bad intent. It is the predictable consequence of asking organizations to optimize for two economic models at once. A health system cannot fully embrace population accountability while treating every reduction in utilization as lost production. A payer cannot ask a provider to cannibalize revenue without creating a credible mechanism for sharing the value that results.

Visibility therefore does more than support oversight. It makes a more explicit economic negotiation possible. If the parties can reliably distinguish necessary care from avoidable variation, attribute outcomes, and measure changes over time, they could begin to design payment around demonstrated capability and results rather than generalized trust or blunt utilization controls.

What changes when confidence increases

Greater confidence should not mean the absence of governance. It should mean more selective governance. Providers that can demonstrate effective risk management should face fewer indiscriminate controls and more clearly defined accountability. Payers should retain the ability to intervene when evidence shows material variation, noncompliance, or harm, but the intervention should be proportionate to the demonstrated risk.

This creates the possibility of a differentiated operating model. Provider organizations that can demonstrate effective capability could earn greater clinical and administrative autonomy, more favorable delegation, preferred partnership status, or economics that recognize their contribution to affordability and outcomes. Where comparable capability has not been demonstrated, more traditional controls may remain appropriate.

Such differentiation would be difficult. Measures can be incomplete. Attribution can be disputed. Data can appear precise while masking important limitations. Market power can overwhelm performance. Even so, adjusting oversight to demonstrated capability may offer a more credible direction than applying the same friction to every provider regardless of performance.

An emerging logic for healthcare governance

The relationship can be understood as a sequence. Each stage depends on the reliability of the stage before it.